(Q37322940)
Statements
1 reference
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with tremelimumab (CP-675,206). (English)
1 reference
Antoni Ribas
1 reference
1 January 2008
1 reference
1 reference
13 Suppl 4
1 reference
10-15
1 reference
1 reference
Identifiers
1 reference
1 reference